MarketPulse — Real-Time Financial News & Market Analysis

UAMY shares jump 11.64% following Trump's five-day pause on Iranian strikes. Oil prices plunge 8%, easing inflation concerns and boosting precious metals demand.

Venture Global secured $8.6B financing and signed 1.5 MTPA LNG supply deal with Vitol through 2026, beating Q1 earnings estimates.

$QCOM tumbles 28% from January highs due to weak Q2 guidance and memory chip shortage, but analysts see buying opportunity in edge computing tailwinds.

Shell repurchased 3.2 million shares at 32.79-39.47 EUR across European exchanges via Morgan Stanley, continuing its capital return program to shareholders.

GE Vernova projects 12-24 GW gas power orders in Q1 2026, doubling backlog to $60B by 2028 amid surge in data center and grid modernization demand.

Class action lawsuit filed against $HTGC alleging overstated due diligence and misrepresented portfolio valuations in loan origination and deal sourcing processes.

Philadelphia law firm sues $ROBLOX, $SNAP, Discord alleging platform designs enabled sexual exploitation of minor through inadequate safety measures.

Nvidia rallies 1.44% to $175.18 on Iran tensions relief and announces AI factory partnership with six major energy companies.

Planet Labs PBC surged 388% in 2025 on strong earnings growth and defense demand. The satellite imaging leader guides FY2027 revenue of $427.5M, but valuation concerns loom.

Lululemon stock down nearly 50% amid CEO departure, weak North American sales, and sluggish 2026 growth guidance. International gains offer hope.

Alight Inc. faces securities fraud lawsuit after missing guidance twice, with stock falling 18-38%. Shareholders can claim losses through May 2026.

CRISPR Therapeutics stock declined 9% following a $585.2M convertible notes offering. The gene-editing company boasts FDA-approved Casgevy therapy and $1.8B in reserves but faces steep losses.

Ondas Holdings surged Monday on blowout Q4 revenue of $30.1M (629% YoY growth) and Q1 guidance of $38-40M, despite EPS miss and expected widening losses.

Eli Lilly announces $3B China investment and Mounjaro reimbursement win, but faces multibillion-dollar lawsuit over Actos disclosures.

U.S. equities rally on Trump's five-day Iran strike pause. Oil tumbles 8%, small caps outperform with 2.58% gain.

Sarissa Capital deploys $5.79M in beaten-down biotech Biohaven despite 70% stock decline, betting on upcoming late-stage trial data and obesity candidate.

$MP down 47% from peaks yet secures landmark DOD partnership with $110/kg price floor, targeting doubled revenue by 2026.

Getty Copper appoints Ryan O'Regan as CEO and Dr. Roy Greig as VP Exploration, grants 22.45M stock options, and hires marketing firms to boost investor awareness.

Domestic box office jumps 20% year-over-year, positioning Cinemark, IMAX, and EPR Properties to benefit from theater sector revival.

Major firms project 3-6.7% annual S&P 500 returns over next decade, down from 12.9% recently, citing tech stock overvaluation concerns.